blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2037930

EP2037930 - THE USE OF 1,4-DIARYL-DIHYDROPYRIMIDINE-2-ON DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTENSION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.09.2010
Database last updated on 03.09.2024
Most recent event   Tooltip17.09.2010Application deemed to be withdrawnpublished on 20.10.2010  [2010/42]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2009/38]
Former [2009/37]For all designated states
Bayer Schering Pharma AG
Müllerstrasse 178
13353 Berlin / DE
Former [2009/13]For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
Inventor(s)01 / VON NUSSBAUM, Franz
Friedenstr. 75
40219 Düsseldorf / DE
02 / GIELEN-HAERTWIG, Heike
Claire-Waldoff-Str. 23
40789 Monheim / DE
03 / KLEIN, Martina
Bahnhofstr. 15
40489 Düsseldorf / DE
04 / LI, Volkhart, Min-Jian
Im Wiesengrund 40
42553 Velbert / DE
05 / MEIBOM, Daniel
Dönfoffstr. 80
51373 Leverkusen / DE
06 / SANDNER, Peter
Julius-Lucas-Weg 59
42113 Wuppertal / DE
07 / LUSTIG, Klemens
Falkenberg 159
42113 Wuppertal / DE
08 / SCHÄFER, Stefan
Frankfurter Allee 8
65835 Liederbach / DE
 [2009/13]
Application number, filing date07764815.225.06.2007
[2009/13]
WO2007EP05579
Priority number, dateDE2006103131401.07.2006         Original published format: DE102006031314
[2009/13]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2008003412
Date:10.01.2008
Language:DE
[2008/02]
Type: A1 Application with search report 
No.:EP2037930
Date:25.03.2009
Language:DE
The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application.
[2009/13]
Search report(s)International search report - published on:EP10.01.2008
ClassificationIPC:A61K31/513, C07D239/22, C07D401/02
[2009/13]
CPC:
C07D239/22 (EP); A61P11/00 (EP); A61P43/00 (EP);
A61P9/12 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/13]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:VERWENDUNG VON 1,4-DIARYL-DIHYDROPYRIMIDIN-2-ON-DERIVATEN ZUR BEHANDLUNG DER PULMONALEN ARTERIELLEN HYPERTONIE[2009/13]
English:THE USE OF 1,4-DIARYL-DIHYDROPYRIMIDINE-2-ON DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTENSION[2009/13]
French:UTILISATION DE DÉRIVÉS DE 1,4-DIARYL-DIHYDROPYRIMIDIN-2-ONE POUR LE TRAITEMENT DE L'HYPERTENSION ARTÉRIELLE PULMONAIRE[2009/13]
Entry into regional phase02.02.2009National basic fee paid 
02.02.2009Designation fee(s) paid 
02.02.2009Examination fee paid 
Examination procedure02.02.2009Examination requested  [2009/13]
25.08.2009Despatch of a communication from the examining division (Time limit: M08)
05.05.2010Application deemed to be withdrawn, date of legal effect  [2010/42]
04.06.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/42]
Fees paidRenewal fee
30.06.2009Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.06.201004   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO2005082864  (BAYER HEALTHCARE AG [DE], et al) [X] 1-13 * page 1, line 2 - line 4; figures (I),(IA) * * page 25, line 6 - page 26, line 15; examples 1-98 * [Y] 1-13;
 [X]WO2005082863  (BAYER HEALTHCARE AG [DE], et al) [X] 1-13 * page 19, line 3; figure (IA); examples 1-85 *;
 [PX]WO2006136857  (ARGENTA DISCOVERY LTD [GB], et al) [PX] 1-13 * Zwischenprodukte; page 17 *;
 [X]WO2004024700  (BAYER HEALTHCARE AG [DE], et al) [X] 1-13 * page 1, line 3 - line 6; figures (I),(IA) * * page 21, line 20; examples 1-111 *;
 [Y]WO2005007124  (SQUIBB BRISTOL MYERS CO [US], et al) [Y] 1-13 * page 25, paragraph 1; figure I * * page 29, line 15 - page 31, line 16 *;
 [Y]WO2005009392  (SQUIBB BRISTOL MYERS CO [US], et al) [Y] 1-13 * page 1, line 9 - line 12 * * page 50, line 20 - line 22 * * page 54, line 26 - page 56, line 27 *;
 [Y]WO2004024701  (BAYER HEALTHCARE AG [DE], et al) [Y] 1-13 * page 22, line 11; figure (IC); examples 1-63 *
Examination   - PETKOV V, "Pulmonary hypertension", JOURNAL FUER HYPERTONIE, (2003), vol. 7, no. 3, pages 7 - 15
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.